Benjamin P. Blumel

Array ( [id] => 14388435 [patent_doc_number] => 10307475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-04 [patent_title] => Methods and compositions for immunization against virus [patent_app_type] => utility [patent_app_number] => 14/182296 [patent_app_country] => US [patent_app_date] => 2014-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 21 [patent_no_of_words] => 26020 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14182296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10489793 [patent_doc_number] => 20150374814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'Polyvalent Fusion Protein Vaccine Against Influenza' [patent_app_type] => utility [patent_app_number] => 14/768107 [patent_app_country] => US [patent_app_date] => 2014-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7488 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11357397 [patent_doc_number] => 09534041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-03 [patent_title] => 'Monoclonal antibodies that neutralize a norovirus' [patent_app_type] => utility [patent_app_number] => 14/767274 [patent_app_country] => US [patent_app_date] => 2014-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 34742 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11520538 [patent_doc_number] => 09603920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Compositions and methods for treating influenza' [patent_app_type] => utility [patent_app_number] => 14/161842 [patent_app_country] => US [patent_app_date] => 2014-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20578 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14161842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10468883 [patent_doc_number] => 20150353900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'INFLUENZA VIRUS REASSORTMENT' [patent_app_type] => utility [patent_app_number] => 14/762439 [patent_app_country] => US [patent_app_date] => 2014-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 26548 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14762439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10850532 [patent_doc_number] => 08877210 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Influenza hemagglutinin and neuraminidase variants' [patent_app_type] => utility [patent_app_number] => 14/156284 [patent_app_country] => US [patent_app_date] => 2014-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 29589 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14156284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12166948 [patent_doc_number] => 09885715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-06 [patent_title] => 'Real-time detection of influenza virus' [patent_app_type] => utility [patent_app_number] => 14/155150 [patent_app_country] => US [patent_app_date] => 2014-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 16880 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14155150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9545494 [patent_doc_number] => 20140170142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'Molecules With Extended Half-Lives And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/153759 [patent_app_country] => US [patent_app_date] => 2014-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19607 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14153759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090235 [patent_doc_number] => 09127049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Human cytomegalovirus neutralizing antibodies and use thereof' [patent_app_type] => utility [patent_app_number] => 14/138531 [patent_app_country] => US [patent_app_date] => 2013-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25105 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12405225 [patent_doc_number] => 09968670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Influenza virus vaccines and uses thereof [patent_app_type] => utility [patent_app_number] => 14/652643 [patent_app_country] => US [patent_app_date] => 2013-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 79 [patent_no_of_words] => 94500 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13675227 [patent_doc_number] => 20160376347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => ANTI-INFLUENZA ANTIBODY [patent_app_type] => utility [patent_app_number] => 14/651043 [patent_app_country] => US [patent_app_date] => 2013-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12136 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14651043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10193002 [patent_doc_number] => 09221897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Human cytomegalovirus neutralizing antibodies and use thereof' [patent_app_type] => utility [patent_app_number] => 14/096283 [patent_app_country] => US [patent_app_date] => 2013-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25074 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14096283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11750582 [patent_doc_number] => 09708585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Influenza virus reassortment' [patent_app_type] => utility [patent_app_number] => 14/648886 [patent_app_country] => US [patent_app_date] => 2013-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 16902 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10012702 [patent_doc_number] => RE045564 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2015-06-16 [patent_title] => 'Canine influenza virus and related compositions and methods of use' [patent_app_type] => reissue [patent_app_number] => 14/075618 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 10560 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9491620 [patent_doc_number] => 20140142026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'Anti-Pathogen Treatments' [patent_app_type] => utility [patent_app_number] => 14/070709 [patent_app_country] => US [patent_app_date] => 2013-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 87 [patent_no_of_words] => 93513 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14070709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10414257 [patent_doc_number] => 20150299267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'PR13.5 PROMOTER FOR ROBUST T-CELL AND ANTIBODY RESPONSES' [patent_app_type] => utility [patent_app_number] => 14/437939 [patent_app_country] => US [patent_app_date] => 2013-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8419 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10669655 [patent_doc_number] => 20160015800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'NASAL INFLUENZA VACCINE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 14/653131 [patent_app_country] => US [patent_app_date] => 2013-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5481 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12198582 [patent_doc_number] => 09901632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-27 [patent_title] => 'Human herpesvirus immunotherapy' [patent_app_type] => utility [patent_app_number] => 14/436239 [patent_app_country] => US [patent_app_date] => 2013-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 20338 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685350 [patent_doc_number] => 20140242114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'cDNA CONSTRUCT OF SALMONIDAE ALPHAVIRUS' [patent_app_type] => utility [patent_app_number] => 14/057328 [patent_app_country] => US [patent_app_date] => 2013-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6849 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14057328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777395 [patent_doc_number] => 08852595 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/051365 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23115 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14051365 [rel_patent_id] =>[rel_patent_doc_number] =>)